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Research
The dramatic increase in the prevalence of 
childhood asthma in developed coun­
tries over the last two to three decades sug­
gests that environmental changes related to 
industrializa  tion may be involved in this 
epidemic (McCoy et al. 2005). One public 
health approach to understanding the asthma 
epidemic would be to identify environ  mental 
exposures that increased during the period 
when asthma prevalence began to increase in 
industrialized countries and to test their effects 
in experimental animals. Those compounds 
that enhance various features of asthma might 
be candidates for promoting the development 
or morbidity of asthma in humans. However, 
even the major reductions in some air pol­
lutants accomplished in many areas have yet 
to have major impacts on the prevalence or 
even the morbidity of asthma. This experi­
ence suggests that the multi  factorial nature of 
the disease makes it difficult to see the effects 
of incremental improvements in our environ­
ment when exposures to other types of toxi­
cants persist or even increase.
We recently found that exposing cultured 
mast cells to estradiol (E2) strongly potentiates 
the synthesis and release of allergic mediators, 
acting through a membrane form of estrogen 
receptor α (ERα) (Zaitsu et al. 2007). We 
also examined the effects of environ  mental 
estrogens, alone and in combination with 
physiologic concentrations of E2, on the acti­
vation of a human mast cell line and primary 
cultures of murine mast cells (Narita et al. 
2007). Like E2, low concentrations of envi­
ronmental estrogens caused a rapid, partial 
degranulation of mast cells. Exposing HMC­1 
cells (a human mast cell line) to a combination 
of suboptimal concentrations of E2 and an 
environmental estrogen had an additive effect 
on degranulation. Environmental estrogens 
also enhanced the release of β­hexosaminidase 
induced by allergen cross­linking of IgE 
(immunoglobulin E) on the surface of these 
cells. Bone­marrow–derived mast cells defi­
cient in ERα expression had significantly 
reduced responses to some concentrations of 
environmental estrogens, suggesting that the 
degranulating activity of environmental estro­
gens on mast cells is mediated, at least in part, 
through ERα and that the dose response is 
non  monotonic, as previously described for 
non  genomic responses to endogenous and 
environmental estrogens (Bulayeva and 
Watson 2004). Recent studies suggest that 
mast cells, in addition to their role as effects of 
allergic reactions, also contribute to the process 
of allergic sensitization (Nakano et al. 2009; 
Sayed and Brown 2007). We therefore exam­
ined whether environmental estrogens might 
enhance allergic sensitization and inflamma­
tion, thereby promoting the develop  ment of 
asthma and other allergic diseases.
To better understand the potential for 
environmental estrogens to promote the 
develop  ment of childhood asthma, in the pres­
ent study we tested the hypothesis that prenatal 
and/or neonatal exposures to one of the most 
ubiquitous environmental estrogens, BPA, 
enhance the development of allergic asthma in 
a susceptible animal model. BPA is a substrate 
of polycarbonate plastics and has been pro­
duced in increasingly large quantities in indus­
trialized countries since the 1950s. BPA is used 
to form plastic bottles, as a lining for food and 
beverage cans, and as a flame retardant and is a 
component of dental fillings. Interestingly, the 
increase of asthma prevalence among children 
started in the 1970s (Vollmer et al. 1998), 
20 years (approximately one generation) after 
large­scale BPA production started in several 
industrialized regions of the world.
Materials and Methods
Animals. Female BALB/c mice were obtained 
from Harlan (Houston, TX) and were housed 
in pathogen­free conditions in the animal 
research facility of the University of Texas 
Medical Branch (UTMB; Galveston, TX) in 
accordance with the National Institutes of 
Health and UTMB institutional guidelines for 
animal care. Each mother and her litter were 
housed separately and fed a casein­based diet 
(Research Diet, New Brunswick, NJ) to elimi­
nate estrogenic effects in the typical soy­based 
mouse diet from 1 week before BPA load­
ing until the end of the study (Curran et al. 
2004). We used animal cages made of poly­
sulfone (Tecniplast, Buguggiate, Italy). We 
tested these cages for contamination with BPA 
by adding water to a cage and maintaining it 
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for 1 week at room temperature. The concen­
tration of BPA in the water was assayed with 
a highly sensitive gas chromatography–mass 
spectrometry (GC­MS) method (detection 
limit, 0.01 pg/mL). We found no detectable 
levels of BPA in the water. All experimenta­
tion was conducted under a protocol approved 
by the UTMB Institutional Review Board. 
The animals were treated humanely and with 
regard for alleviating suffering.
We compared the following study groups: 
a) BPA exposed and ovalbumin (OVA)   
sensitized/challenged (BPA­OVA); b) BPA 
exposed and not sensitized/challenged 
(BPA­PBS); c) not BPA exposed but OVA 
sensitized/challenged (N­OVA); and d) not 
BPA exposed and sham sensitized/challenged 
(N­PBS).
BPA loading of female mice and pups. To 
simulate the relevant sources of BPA exposure 
in the human fetus and infant, we fed BPA 
(Sigma, St. Louis, MO) to the female mice 
before pregnancy. Female BALB/c mice were 
given 10 µg/mL BPA in 1% ethanol solution in 
their drinking water for 1 week before mating 
and throughout their pregnancy and lactation. 
We chose the concentration of BPA to feed the 
female mice based on a previous study (Kabuto 
et al. 2004) in which the body burdens of free 
BPA in the mothers and pups were similar to 
those described in human tissues and fluids. In 
that study, 5 or 10 µg/mL BPA in the mother’s 
drinking water resulted in 10–8 to 10–7 M con­
centrations in neo  natal tissues, which is in the 
range reported from environmentally exposed 
humans (Table 1). Control female mice were 
given 1% ethanol solution in their drinking 
water from 1 week before mating until the end 
of the study. All of the outcome measures were 
performed only on pups.
Allergic sensitization and exposure. To 
detect effects of BPA on allergic sensitization, 
we gave suboptimal doses of OVA to the pups, 
as described previously (Fedulov et al. 2008; 
Hamada et al. 2007). A single intraperitoneal 
(ip) injection of 5 µg OVA with 1 mg alum 
(Sigma) as an adjuvant was given on postnatal 
day 4 (PND4). These mice were subsequently 
exposed to aerosolized 3% OVA solution in 
phosphate­buffered saline (PBS) for 10 min 
on PNDs 13, 14, and 15, using a jet nebu­
lizer (Pari II; Pari Industries, Richmond, VA). 
Markers of the development of asthma were 
assessed on PND17. 
Pulmonary function testing. To assess 
airway hyper  responsiveness (AHR), we used 
whole­body barometric plethysmography 
(Buxco Electronics, Sharon, CT) 48 hr after 
the OVA challenge on PND17 (Leme et al. 
2006) as previously described (Castro et al. 
2006). Measurements of airway responses 
were performed on individual, unrestrained, 
non  anesthetized mice in a four­chamber 
plethysmograph. AHR was expressed as an 
enhanced pause (Penh), a dimensionless 
parameter used to measure pulmonary resis­
tance, calculated from changes in the pattern 
of chamber pressure induced by methacholine 
challenge. After a brief acclimatization in the 
chamber, the mice received an initial baseline 
challenge of saline, followed by increasing 
doses of nebulized methacholine (1, 10, 25, 
and 50 mg/mL). Recordings were taken for 
3 min after each nebulization. The respira­
tory rate in breaths per minute was extrapo­
lated from readings of every 10 breaths. The 
box pressure waveforms generated from the 
respiratory cycle were used to calculate peak 
expiratory pressure (PEP), peak inspiratory 
pressure (PIP), and the time of expiration. 
Penh was then calculated using the formula 
Penh = pause × PEP/PIP. Penh values were 
averaged and reported as a percentage of base­
line nebulized saline inhalation.
Some of the pups from each treatment 
group were analyzed using the forced oscilla­
tion technique (flexiVent; SCIREQ, Montreal, 
Quebec, Canada) to validate the results of the 
whole­body barometric plethysmography, as 
described previously by Shore et al. (2003). 
Briefly, we treated these animals similarly to 
those described above, except we gave them 
aerosolized 3% OVA on PNDs 18–20. On 
PND22 (48 hr after the last aerosol chal­
lenge), animals were anesthetized with xyla­
zine (7 mg/kg) and pento  barbital sodium 
(50 mg/kg). After performing a tracheostomy, 
we used a tubing adaptor (19 gauge; Becton­
Dickinson, Franklin Lakes, NJ) to cannu­
late the trachea and then ventilated the mice 
at 150 Hz with a tidal volume of 0.3 mL. 
Pressure at the airway opening was meas  ured 
by the flexiVent system. We applied a posi­
tive end­expiratory pressure of 3 cm H2O. 
We used a 2.5­Hz sinusoidal forcing function 
to meas  ure dynamic pulmonary resistance 
(RL) by the forced oscillation technique. We 
obtained dose–response curves to nebulized 
methacholine (0.1, 1, 10, 30 and 50 mg/mL); 
the five highest values of RL obtained after 
each dose were averaged to obtain the final 
values for each dose.
Quantifying the inflammatory cells in bron-
choalveolar lavage (BAL) fluid. On PND17, 
mice were sacrificed, and total leuko  cytes 
and eosinophils in BAL fluid were counted. 
Immediately after sacrifice, cells in the lungs 
were recovered by flushing the isolated trachea 
with 0.5 mL PBS twice. Total leuko  cytes were 
counted using a hemo  cytometer. Eosinophil 
Table 1. Reported free BPA concentrations in human samples.
Sample Location Method Free BPA level (ng/mL) Reference
Plasma, pregnant USA HPLC 0.5–22.3 Padmanabhan et al. 2008
Plasma Germany LC-MS < 0.5 Volkel et al. 2005
Plasma, maternal Germany GC-MS 0.3–18.9 Schonfelder et al. 2002
Plasma, cord Germany GC-MS 0.2–9.2 Schonfelder et al. 2002
Serum, maternal Japan HPLC 0.46 ± 0.20 Kuroda et al. 2003
Serum, cord Japan HPLC 0.62 ± 0.13 Kuroda et al. 2003
Serum Belgium GC-MS 0.98 ± 1.09 Dirtu et al. 2008
Urine USA HPLC < 0.3–0.6 Ye et al. 2005
Urine, men Korea HPLC 0.28–2.36 Kim et al. 2003
Urine, women Korea HPLC 0.068–1.65 Kim et al. 2003
Urine Japan GC-MS 0.01–0.27 Tsukioka et al. 2003
Urine Germany LC-MS < 1.14 Volkel et al. 2005
Breast milk Japan HPLC 0.61 ± 0.20 Sun et al. 2004
Adipose tissue, women Spain GC-MS 5.83 ± 3.48 Fernandez et al. 2007
Placenta Germany GC-MS 1.0–104.9 Schonfelder et al. 2002
Abbreviations: HPLC, high-performance liquid chromatography; LC-MS, liquid chromatography–mass spectrometry.
Figure 1. BPA effects on AHR after methacholine challenge. The lung function of the pups was analyzed by 
(A) whole-body barometric plethysmograph on PND17 (challenged with 0, 1,10, 25, or 50 mg/mL methacho-
line) or (B) forced oscillation analysis on PND22 (challenged with 0, 0.1, 1, 10, 30, or 50 mg/mL methacholine). 
R, lung resistance. Data are mean ± SE (n = 7–11). Analysis was performed on pups from 4–6 mothers and 
divided into OVA and sham immunization groups. 
*p < 0.05 compared with all other groups after 25 mg/mL and 50 mg/mL methacholine by whole-body barometric 
plethysmo  graph and after 30 mg/mL by the forced oscillation analysis.
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counts were calculated from differential cell 
counts in 150 µL fluid deposited onto glass 
slides using a Cytospin 3 centrifuge (400 × g 
for 4 min; Shandon Lipshaw, Pittsburgh, 
PA) and stained with hematoxylin and eosin 
(Anderson and Poulsen 2003). The results were 
expressed as the absolute number of total cells 
and eosinophils.
Quantification of OVA-specific anti  bodies 
in mouse sera. To evaluate the effects of the 
environmental estrogen BPA on in vivo sensi­
tization, we measured allergen­specific IgE and 
IgG1 in the sera of the mouse pups at the time 
of sacrifice. Individual measurements of IgE 
and IgG1 were performed by ELISA (enzyme­
linked immunosorbent assay). We used OVA­
specific monoclonal IgE and IgG1 anti  bodies 
(Gene Tex, Inc., San Antonio, TX) as stan­
dards, and biotinylated anti­mouse IgE (R&D 
Systems, Minneapolis, MN) and horseradish 
peroxidase anti­mouse IgG (H&L; Zymed, 
San Francisco, CA) for detection. The detec­
tion limit for both IgE anti­OVA and IgG 
anti­OVA was 5 ng/mL. Values below the 
detection limit are shown on the baseline.
Statistical analysis. Results are expressed 
as the mean ± SE. Statistical analysis was 
performed using one­way analysis of vari­
ance. Where differences between groups 
were present, they were further analyzed by 
the Student’s t­test. A p­value of < 0.05 was 
defined as statistically significant.
Results
The effect of BPA exposure on pregnancy. We 
found no significant differences in the BPA­
exposed and unexposed mothers in time to 
impregnation, litter size, birth weights, or sex 
ratio of the pups (data not shown).
Effect of BPA on allergen-induced AHR. 
Figure 1 shows the effect of BPA exposure on 
the development of AHR as assessed by whole­
body barometric plethysmograph and the 
forced oscillation technique. Airway respon­
siveness to methacholine was significantly 
increased in BPA­OVA pups compared with 
all other groups using both methods of analy­
sis. These differences were present in response 
to both 25 and 50 mg/mL methacholine 
when meas  ured by whole­body barometric 
plethysmograph and 30 mg/mL by the forced 
oscillation technique. The patterns of Penh 
and lung resistance responses to methacholine 
were quite similar. This result is consistent 
with a previous report by Adler et al. (2004) 
in BALB/c mice that showed a signifi  cant cor­
relation between Penh and lung resistance.
Effect of BPA on pulmonary inflammation. 
To determine whether BPA alters allergen­in­
duced pulmonary inflammation, we quantified 
total and differential cell counts in BAL fluid. 
We observed a significant increase in eosinophils 
in BAL fluid from BPA­OVA pups (Figure 2B) 
compared with all other groups. We found no 
significant difference in the total cell number 
between the groups (Figure 2A). We derived 
the data for each group from 6–7 mothers 
and 12–16 pups. Pups from each litter were 
distributed in both the OVA­sensitized and 
non  sensitized groups, so the unit of analysis 
was the individual pups. Statistical analysis was 
performed with and without the inclusion of 
the BPA­OVA outlier shown in Figure 3. Both 
analyses showed p < 0.05 for eosinophil con­
centration in BAL fluid from BPA­OVA pups 
compared with all other groups. 
Effect of BPA on allergen-specific antibody 
production. The concentration of IgE anti­
OVA antibodies in the sera from BPA­OVA 
pups was significantly higher than that for the 
other three groups (p < 0.05; Figure 3). IgG1 
anti­OVA concentrations in sera from these 
four groups of pups did not differ. Statistical 
analysis performed with and without the out­
lier (BPA­OVA pup) showed statistical sig­
nificance (p < 0.05) for IgE anti­OVA in the 
sera from BPA­OVA pups compared with 
all other groups, but no significance for IgG 
anti­OVA concentrations. The outlier in 
Figure 3 was the same BPA­OVA pup with 
the high eosinophil number in the BAL fluid 
(Figure 2B).
Discussion
To begin testing the hypothesis that expo­
sure of genetically susceptible animals to an 
environ  mental estrogen during critical peri­
ods of immune development promotes aller­
gic sensitization and enhances subsequent 
inflammatory reactions, we chose to analyze 
the responses of neo  natal mice to BPA expo­
sure during the peri  natal period. We found 
that AHR, eosinophilic inflammation, and 
allergen­specific IgE were all significantly 
increased in the allergen­sensitized/challenged, 
BPA­exposed pups compared with those that 
were not exposed to BPA or not sensitized 
to OVA. These findings are quite consistent 
with our hypothesis. The BALB/c strain of 
mice is considered to be susceptible to allergic 
sensitization and has been used extensively as 
a model of allergic asthma after sensitization 
with OVA. However, most studies of OVA­
induced asthma in BALB/c mice have started 
the sensitization process later in life and have 
used multiple and larger ip doses of OVA to 
prime the allergic response and larger inhaled 
doses to complete the sensitization and to 
induce airway inflammation and hyperreactiv­
ity. We chose an intentionally “sub  optimum” 
sensitization protocol that was designed and 
used extensively by Kobzik and colleagues 
(Fedulov et al. 2008; Hamada et al. 2007) to 
examine maternal influences on development 
of the asthma phenotype in neo  natal BALB/c 
mice. This approach allowed us to demon­
strate in our model that early life exposure to 
BPA enhanced the development of asthma 
under conditions that otherwise would not 
induce this phenotype. However, the present 
study does not exclude the possibility that 
exposure to BPA in utero only, during early 
infancy only, or even in adulthood may have 
similar effects on the development or manifes­
tations of asthma.
Our finding that BPA exposure enhanced 
allergic sensitization (serum IgE anti­OVA 
Figure 2. BPA effects on OVA hypersensitivity. Total cell number (A) and eosinophil counts (B) in BAL fluid 
13 days after ip injection with OVA or PBS. The result for each pup is shown as an individual point (n = 12–16 
pups from 6–7 mothers per group), and the bars indicate the mean ± 1 SE for groups. 
*p < 0.05 compared with all other groups. 
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anti  bodies), eosinophilic airway inflammation, 
and bronchial hyperreactivity does not allow 
us to distinguish primary from secondary or 
tertiary effects of BPA on the development 
of these components of the asthma pheno­
type. However, because exposure to both BPA 
and OVA was required to induce AHR in our 
model, it seems very likely that allergic sensiti­
zation is required for BPA to promote asthma 
development, although sensitization alone may 
not be sufficient to induce the asthma pheno­
type. This proposition is in keeping with the 
study by Ohshima et al. (2007) that found 
that BPA exposure in mice also promotes the 
manifestation of food allergy in orally sensi­
tized mice. Our finding that our BPA expo­
sure/OVA sensitization protocol did not cause 
an increase in mouse IgG1 antibodies to OVA 
[another T­helper cell (TH2)­driven isotype] 
may be explained by the recent finding that 
IgG1 is a switch intermediate between IgM and 
IgE expression (Sudowe et al. 1997). Because 
BPA has been shown to induce production of a 
large amount of interleukin­4 (IL­4) (Johnson 
et al. 1996; King et al. 1998; Siegrist 2001), 
this may drive the IgG1­expressing B cells on 
to IgE expression. However, this finding may 
also be a manifestation of the immaturity of 
the B­cell system at this age (Johnson et al. 
1996; King et al. 1998; Siegrist 2001).
The key cell types and mechanisms by 
which BPA promotes allergic asthma in mouse 
pups remain to be elucidated. However, a 
number of sex steroid effects on immune sys­
tem functions have been described (Watson 
and Gametchu 2001), although relatively few 
have been explored mechanistically. Estrogens 
(10–7 M E2, nonylphenol, and octylphenol) 
promote a TH2 response associated with 
increased IL­4 and decreased interferon­γ 
(IFN­γ) production from CD4+CD8+ thy­
mocytes and naive CD4+ T cells isolated from 
C57BL/6 mice (Iwata et al. 2004). Lambert 
et al. (2005), using cells from an ERα knock­
out mouse on a C57BL/6 background, found 
that 10–9 M E2 acts through ERα to increase 
IL­4 and GATA­3 expression and essential 
TH2 cytokine and transcription factors in 
CD4+ cells and to reduce IFN­γ production 
from macrophages. E2 (10–8 to 10–6 M) also 
has effects on major histocompatibility com­
plex class II expression on spleen dendritic 
cells isolated from BALB/c mice (Yang et al. 
2006). High concentrations of BPA (10–5 to 
10–4 M) and nonyl  phenol (10–7 to 10–6 M) 
have been shown to induce IL­4 and IgE pro­
duction from CD4+ T cells (Lee et al. 2003).
Environmental toxins are encountered 
to varying extents in both industrialized 
and developing nations and rural and urban 
environ  ments. Some of these compounds are 
by­products of industrial plants or agricul­
ture, such as pesticides. They often contami­
nate water supplies, exposing fish and other 
animals, including humans. Although the 
World Health Organization strongly supports 
breast­feeding, breast­milk monitoring stud­
ies suggest that environmental chemicals that 
may affect children’s health are transmitted 
through breast­feeding (Solomon and Weiss 
2002; Wang et al. 2004). This is especially 
true for environmental lipid­soluble pollut­
ants such as poly  halogenated compounds, 
because these chemicals tend to degrade 
slowly in the environment, bioaccumulate 
and bioconcentrate in the food chain, and 
have long half­lives in humans. Because the 
fat content of breast milk is relatively high, 
the concentration of some of these pollutants 
is 100 times higher in maternal milk than in 
plasma (Dewailly et al. 1993). As the final 
consumers in the food chain, human infants 
may consume the highest concentrations of 
lipid­soluble environ  mental pollutants, which 
might enhance their risk of developing asthma 
or other allergic diseases due to the actions of 
environ  mental estrogens.
Newborns generally have a TH2­skewed 
pattern of immunity, partially due to low pro­
duction of IL­12 and the propensity of TH1 
cells to undergo apoptosis after antigen expo­
sure (Allam et al. 2005; Prescott et al. 1998). 
Subsequently, “immune­maturing” infec­
tions are thought to promote a shift toward 
TH1 responses in most children, whereas 
some remain prone to develop TH2 responses 
(Prescott et al. 1999) and their disease con­
sequences. In keeping with this progres­
sion, most cases of asthma develop in early 
childhood. Thus, environmental exposures 
in utero and during first months of life are 
likely to be very important (Holt and Jones 
2000). Further, Gern et al. (1999) found that 
asthma, at any age, is likely to originate in 
childhood or earlier. Therefore, immunologic 
events in children and experimental models 
of airway injury and repair in early life may 
provide important clues to the inception and 
pathogenesis of asthma.
We observed that our adult mice drank 
about 5 mL of 10­µg/mL BPA in their water 
and therefore estimate that they consumed 
about 2 mg/kg/day of BPA. Lee et al. (2003) 
reported that injection of keyhole limpet 
hemocyanin (100 µg) into the footpad fol­
lowed by BPA (25 mg/kg/day) or nonyl­
phenol (5 mg/kg/day) by ip injection induced 
production of both IL­4 and IgE in adult 
mice. It is possible that the mice in their 
study had higher tissue levels of BPA than did 
ours, because we found that the range of envi­
ronmental estrogens that induced mast cell 
degranulation in vitro was somewhat broad, 
10–11 to 10–9 M (Narita et al. 2007), sug­
gesting that a broad range of BPA may also 
promote allergic sensitization in vivo.
The results described here indicate that we 
must give due consideration to the possible 
impact of environmental estrogens on normal 
immune development and on the develop­
ment and morbidity of immunologic diseases, 
such as asthma. More extensive studies are 
required to analyze the cellular and molec­
ular mechanisms that underlie these effects 
during specific developmental windows and 
thus identify approaches to prevent exposures 
or remediate effects of the xeno  estrogens. 
Understanding the implications of our study 
for human asthma will require epidemiologic 
studies that examine the effect of BPA burden 
of mothers and their children on the risk of 
developing childhood and adult asthma in 
large populations.
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